Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126948981 | 12694898 | 1 | I | 20160817 | 20160829 | 20160829 | EXP | CA-PFIZER INC-2016406336 | PFIZER | 56.00 | YR | F | Y | 0.00000 | 20160829 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126948981 | 12694898 | 1 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, UNK | U | 0 | 50 | MG | |||||||
| 126948981 | 12694898 | 2 | PS | CELEBREX | CELECOXIB | 1 | 200 MG, UNK | U | 20998 | 200 | MG | CAPSULE, HARD | |||||||
| 126948981 | 12694898 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK, WEEKLY | U | 11719 | /wk | |||||||||
| 126948981 | 12694898 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | 500 MG, BID | U | 7073 | 500 | MG | BID | |||||||
| 126948981 | 12694898 | 5 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | 400 MG, QD | U | 0 | 400 | MG | QD | |||||||
| 126948981 | 12694898 | 6 | SS | NAPROSYN | NAPROXEN | 1 | 500 MG, BID | U | 0 | 500 | MG | BID | |||||||
| 126948981 | 12694898 | 7 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 150 MG, QMO | U | 0 | 150 | MG | /month | ||||||
| 126948981 | 12694898 | 8 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | 0 | 1 | G | |||||||
| 126948981 | 12694898 | 9 | SS | SIMPONI | GOLIMUMAB | 1 | Subcutaneous | 50 MG, QMO | U | 0 | 50 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126948981 | 12694898 | 2 | Rheumatoid arthritis |
| 126948981 | 12694898 | 3 | Rheumatoid arthritis |
| 126948981 | 12694898 | 4 | Rheumatoid arthritis |
| 126948981 | 12694898 | 5 | Rheumatoid arthritis |
| 126948981 | 12694898 | 6 | Rheumatoid arthritis |
| 126948981 | 12694898 | 7 | Rheumatoid arthritis |
| 126948981 | 12694898 | 8 | Rheumatoid arthritis |
| 126948981 | 12694898 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126948981 | 12694898 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126948981 | 12694898 | Abdominal pain | |
| 126948981 | 12694898 | Dizziness | |
| 126948981 | 12694898 | Drug ineffective | |
| 126948981 | 12694898 | Drug intolerance | |
| 126948981 | 12694898 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |